| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.21 | 0.007 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |